Babanto, Alexa Mae B.

HRN: 23-96-03  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2024
AMPICILLIN 1GM (VIAL)
05/04/2024
05/11/2024
INTRAVENOUS
250 Mg IVTT
Every 6 Hours
Empiric
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: